T3 Defense Inc. Announces Private Placement of up to $20 Million to Accelerate Acquisition Strategy
T3 Defense (NASDAQ: DFNS) entered definitive agreements for a committed private placement of up to $20 million from existing shareholder Esousa Group Holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
T3 Defense (NASDAQ: DFNS) entered definitive agreements for a committed private placement of up to $20 million from existing shareholder Esousa Group Holdings. The two-tranche financing provides $10 million at closing with a conditional second $10 million tranche tied to registration, shareholder approval, Nasdaq continued-listing compliance and market conditions. Proceeds will target acquisitions in the A&D sector, working capital for multi-year programs, balance sheet flexibility and operational capacity across portfolio companies. Investment is via newly created convertible preferred shares and warrants; investor ownership is limited to 9.99%. Dawson James Securities is exclusive placement agent.
Positive
- $20M committed private placement for acquisition funding
- $10M funded at closing to support immediate needs
- Financing structured as convertible preferred shares + warrants
- Proceeds earmarked for A&D acquisitions, working capital and balance-sheet flexibility
- 9.99% investor ownership limit
Negative
- Second $10M tranche contingent on registration, shareholder approval and Nasdaq compliance
- Convertible preferred and warrants create potential dilution to existing shareholders
Details
News Market Reaction – DFNS
On Feb 25, the day this news came out, DFNS closed 1.88% below the previous close.
Data tracked by StockTitan Argus for the Feb 25 session.
Key Figures
- Private placement size
- $20 million
- Committed two-tranche investment from Esousa Group Holdings
- First tranche funding
- $10 million
- Funded at closing of private placement
- Second tranche commitment
- $10 million
- Subject to effective registration, shareholder approval, Nasdaq conditions
- Ownership cap
- 9.99%
- Maximum ownership limitation for the investor
- Stake in ITS
- 51%
- Majority ownership in Industrial Techno-Logic Solutions
- Estimated annual revenue
- $24–26 million
- Combined revenue estimate after ITS acquisition
- Share price
- $2.13
- Pre-news price level from market context
- Market cap
- $60,961,442
- Pre-news equity value from market context
Historical Context
-
Hired experienced defense and industrial leaders to scale operations and dealflow.
-
Acquired 51% of ITS with no added cash or securities, boosting revenue base.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
private placement financial
warrants financial
registration statement regulatory
Form 8-K regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Two-tranche financing strengthens balance sheet and supports disciplined expansion across defense industrial base
NEW YORK and TEL AVIV, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) -- T3 Defense Inc. (NASDAQ: DFNS), formerly Nukkleus Inc., today announced that it has entered into definitive agreements for a committed private investment for up to
The financing is structured in two tranches, with
The proceeds from the financing are expected to be used to, among other things, advance acquisitions within the A&D sector, support working capital tied to multi-year program execution, strengthen overall balance sheet flexibility, and enhance operational capacity across portfolio companies.
The investment will be made through the issuance of newly created convertible preferred shares together with warrants. The preferred shares will be convertible into common stock pursuant to a formula-based conversion mechanism. The warrants will be included in the registration statement and shareholder approval process and will be subject to customary exercisability conditions. The investor is subject to a
“This committed
Additional details relating to the investment and related matters can be found in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 25, 2026.
Dawson James Securities is acting as the Exclusive Placement Agent for the private placement.
About T3 Defense Inc.
T3 Defense Inc. (NASDAQ: DFNS), formerly Nukkleus Inc., is a federated holding company focused on acquiring and operating mission-critical defense businesses embedded in long-cycle national security programs. The company targets defense businesses operating at constrained, qualification-driven, or execution-critical points across the industrial base where strategic value exists and where qualification, capacity, and execution are decisive. Through disciplined M&A, centralized capital and strategy, and decentralized operating autonomy, T3 Defense seeks to strengthen critical defense capabilities and compound long-term value.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements include, but are not limited to, statements regarding T3 Defense Inc.’s growth strategy; its ability to expand manufacturing throughput, industrial capacity, and production reliability; anticipated benefits of recent executive appointments; expectations regarding subsidiary coordination and operational scalability; the conversion of backlog into repeatable production output; and the Company’s ability to capitalize on structural constraints within the defense industrial base.
Forward-looking statements are based on current expectations, estimates, and projections and involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied in such statements. These risks and uncertainties include, among others, risks related to defense program funding and timing; dependence on government contracts and defense OEM relationships; supply chain constraints; manufacturing execution risks; integration of acquired businesses; availability of capital; and general economic and geopolitical conditions. Readers are encouraged to review the Company’s filings with the Securities and Exchange Commission for a discussion of additional risk factors.
T3 Defense undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Investor Relations Contact:
The Equity Group Inc.
Lena Cati
lcati@equityny.com
+1 (212) 836-9611
Val Ferraro
vferraro@theequitygroup.com
+1 (212) 836-9633
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.